Registration is available

-352

days

7

hours

58

minutes

Registration

Welcome message

Dear Colleagues,

It is my sincere pleasure to invite you to the 1st International Forum on Tuberculosis in Central and Eastern Europe, which will take place in Warsaw, Poland, from 4th to 6th November 2016.
Tuberculosis (TB) has plagued mankind for centuries. It still continues to be a significant health problem throughout the world. With a death toll of 2 million people every year, TB ranks first as the cause of death among all infectious diseases known to afflict human population worldwide, surpassing even HIV/AIDS, malaria or influenza.

Read more

They write about us

Helmi Mardassi, DVM, PhD

I have heard about the outstanding event to be held in Warsaw, which will bring together all TB experts from Central & Eastern Europe with the aim of discussion the most vital issues concerning TB epidemiology in the region. I warmly support the idea and I am quite confident that it will have a huge impact on TB control in the whole region.

Dr. Helmi Mardassi
Head of the Laboratory of Molecular Microbiology, Vaccinology, and Biotechnology Development, Unit of Typing & Genetics of Mycobacteria, Institut Pasteur de Tunis
Read more

I find the idea of this conference extremely beneficial for both experts and non-experts in the field of mycobacteriology. It gives an excellent opportunity to increase the social awareness of TB and to network researchers over TB-related problems."

Prof. Qian Gao
School of Basic Medical Science, Fudan University, Shanghai, China
Read more

Much of the TB burden has accumulated in Eastern Europe. This conference gathering TB experts from virtually all Central and Eastern European countries is believed to provide an important update on the epidemiological situation of TB in this particular region.

Dr. Tomotada Iwamoto
Head of the Department of Infectious Diseases, Kobe Institute of Health, Japan
Read more

I would like to invite you to take part in this conference, as it is devoted to one of the most devastating human diseases – tuberculosis. Of particular value is that the conference focuses on the current state and future developments of research on TB epidemiology in countries bearing much of the global burden of the disease.

Dr. Nalin Rastogi
Director of the WHO Supranational TB Reference Laboratory, Tuberculosis & Mycobacteria Unit, Institut Pasteur de la Guadeloupe, France
Read more

I would highly encourage you to take part in this conference, which is intended to provide an international platform for discussion and exchange of ideas on tuberculosis (TB). TB is the leading killer from a single infectious disease worldwide and drug-resistant TB is now threatening to erode all prior gains in global TB control. Indeed, TB is a real health threat for every major medical subspecialty. The conference targets at assessing challenges and achievements related to TB epidemiology in countries that struggle with a high TB caseload and drug resistance. I believe the conference will be of value to health care providers, public health stakeholders and scientists alike.

Scott K. Heysell MD, MPH
Assistant Professor of Medicine, Infectious Diseases and International Health, University of Virginia, USA. Tuberculosis Research Collaborator, Irkutsk Regional Clinical TB Hospital, Russian Federation
Read more

The problem of ТВ is of particular importance for Sub-Saharan Africa, where the disease is often associated with HIV infection. The presentation of modern achievements in ТВ epidemiology and а free exchange оf opinions between scientists will accelerate the distribution of knowledge on TB in Europe and will be useful for Africa and for the rest of the world as well.

Рrоf. Mamdou Yеrо Boiro
General Directorof the Research Institute on Applied Biology of Guinea Republic of Guinea
Read more
Conference under the title of International Forum on Tuberculosis in Central and Eastern Europe is financed by the Ministry of Science
and Higher Education from the Fund for Science Popularization Activities, Contract No: 912/P-DUN/2016.